Advanced Solid Tumors
Showing NaN - NaN of 49
Advanced Solid Tumors Trial in Worldwide (BMS-986466, Adagrasib, Cetuximab)
Not yet recruiting
- Advanced Solid Tumors
- BMS-986466
- +2 more
-
Birmingham, Alabama
- +24 more
Aug 29, 2023
Advanced Solid Tumors Trial in Canada, United States (LCB84, Anti-PD-1 mAb)
Not yet recruiting
- Advanced Solid Tumors
- LCB84
- Anti-PD-1 monoclonal antibody
-
Los Angeles, California
- +6 more
Jul 4, 2023
Advanced Solid Tumors Trial in Worldwide (BMS-986449, Nivolumab)
Not yet recruiting
- Advanced Solid Tumors
-
Los Angeles, California
- +19 more
May 25, 2023
Advanced Solid Tumors Trial in Worldwide (AMG 650)
Active, not recruiting
- Advanced Solid Tumors
- AMG 650
-
Los Angeles, California
- +21 more
Jan 26, 2023
Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)
Recruiting
- Advanced Cancer
- +24 more
- pembrolizumab
-
Los Angeles, California
- +21 more
Jan 18, 2023
Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation Trial in Worldwide (Sotorasib, AMG 404, trametinib)
Recruiting
- Advanced Solid Tumors
- Kirsten Rat Sarcoma (KRAS) pG12C Mutation
- Sotorasib
- +15 more
-
Tucson, Arizona
- +83 more
Dec 28, 2022
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Crizotinib
- +17 more
-
Birmingham, Alabama
- +125 more
Nov 21, 2022
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in United States (AMG 337)
Completed
- Advanced Malignancy
- +5 more
- AMG 337
-
Los Angeles, California
- +7 more
Nov 3, 2022
Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)
Active, not recruiting
- Advanced Solid Tumors
- +7 more
- Pembrolizumab
- Lenvatinib
-
Duarte, California
- +87 more
Aug 19, 2022
Advanced Solid Tumors, Squamous Cell Carcinoma of the Head and Neck (SCCHN), Gastrointestinal (GI) Malignancies Trial in
Recruiting
- Advanced Solid Tumors
- +2 more
- INCA00186
- +2 more
-
Los Angeles, California
- +31 more
Jul 20, 2022
Advanced Solid Tumors Trial in United States (ARRY-382, Pembrolizumab)
Terminated
- Advanced Solid Tumors
-
Los Angeles, California
- +29 more
May 21, 2022
Advanced Solid Tumors Trial in United States (paclitaxel, FOLFIRI, ABT-165)
Active, not recruiting
- Advanced Solid Tumors
- paclitaxel
- +3 more
-
Scottsdale, Arizona
- +9 more
Mar 23, 2022
Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)
Completed
- Advanced Solid Tumors
- +6 more
- Cabiralizumab
- Nivolumab
-
Scottsdale, Arizona
- +38 more
Jan 5, 2022
Advanced Solid Tumors, Solid Tumors, Ovarian Cancer Trial in Australia, United States (TALZENNA capsule, Talazoparib soft gel
Active, not recruiting
- Advanced Solid Tumors
- +7 more
- TALZENNA capsule
- Talazoparib soft gel capsule
-
Encinitas, California
- +31 more
Feb 14, 2022
Advanced Solid Tumors Trial in Los Angeles (aldoxorubicin)
Completed
- Advanced Solid Tumors
-
Los Angeles, CaliforniaSamuel Oschin Comprehensive Cancer Institute
Jan 27, 2022
Advanced Solid Tumors Trial in Worldwide (ALKS 4230, Pembrolizumab)
Recruiting
- Advanced Solid Tumors
- ALKS 4230
- Pembrolizumab
-
Los Angeles, California
- +48 more
Feb 1, 2022
Advanced Solid Tumors Trial in Worldwide (Intervention)
Completed
- Advanced Solid Tumors
- Intervention
-
Birmingham, Alabama
- +48 more
Jan 18, 2022
Breast Cancer, Ovarian Cancer, Endometrial Cancer Trial in Korea, Republic of, United States (FPA150, Pembrolizumab)
Completed
- Breast Cancer
- +3 more
- FPA150
- Pembrolizumab
-
Scottsdale, Arizona
- +17 more
Jan 6, 2022
Advanced Solid Tumors, NSCLC Trial in United States (Phase I: X-396 (ensartinib), Phase II: X-396 (ensartinib))
Completed
- Advanced Solid Tumors
- Non-small Cell Lung Cancer
- Phase I: X-396 (ensartinib)
- Phase II: X-396 (ensartinib)
-
Duarte, California
- +13 more
Oct 4, 2021